What is GLP-1?

GLP-1 (glucagon-like peptide-1) is a class of medications primarily used for diabetes and weight loss, with emerging effects on addictive behaviors. The material tracks its widespread adoption, safety concerns, and potential broader impacts.

• Mar 2026 - Dr. Rhonda Patrick noted that GLP-1s carry a black box warning for thyroid cancer, though this has not been shown in human studies.
• Apr 2026 - A guest reported emerging data that GLP-1 users show reduced desire for gambling, shopping, alcohol, and smoking, and theoretically could also reduce sexual desire due to shared pathways.
• May 2026 - Jason Calacanis stated that one in eight Americans is currently on a GLP-1.
• May 2026 - Scott Galloway said, “I think GLP1 is more important technology than AI.”